Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Corti

Showing results (171-180 of 202) with videos related to

Pageof 21
Sort By:
Biorxiv : the Preprint Server for Biology|January 20, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Matthew McCallum, Anna De Marco, Florian Lempp, et al.
Nature Medicine|March 5, 2021
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodiesRita E Chen, Xianwen Zhang, James Brett Case, et al.
Iscience|December 12, 2022
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escapeRoberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, et al.
Nature|June 21, 2021
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsRita E Chen, Emma S Winkler, James Brett Case, et al.
Nature Immunology|February 3, 2026
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332<sub>gp120</sub> glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Identification of a broad and potent V3 glycan site bNAb targeting an N332<sub>gp120</sub> glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2022
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escapeRoberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Nature|March 11, 2021
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Science Immunology|November 10, 2022
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccinesJohn E Bowen, Young-Jun Park, Cameron Stewart, et al.
Pageof 21

Showing results (171-180 of 202) with videos related to

Sort By:
Pageof 21
Biorxiv : the Preprint Server for Biology|January 20, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Matthew McCallum, Anna De Marco, Florian Lempp, et al.
Nature Medicine|March 5, 2021
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodiesRita E Chen, Xianwen Zhang, James Brett Case, et al.
Iscience|December 12, 2022
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escapeRoberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, et al.
Nature|June 21, 2021
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsRita E Chen, Emma S Winkler, James Brett Case, et al.
Nature Immunology|February 3, 2026
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332<sub>gp120</sub> glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Identification of a broad and potent V3 glycan site bNAb targeting an N332<sub>gp120</sub> glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2022
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escapeRoberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Nature|March 11, 2021
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Science Immunology|November 10, 2022
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccinesJohn E Bowen, Young-Jun Park, Cameron Stewart, et al.
Pageof 21